{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:47:28Z","timestamp":1790300848785,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.ijantimicag.2007.09.013","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T16:57:32Z","timestamp":1196960252000},"page":"240-244","source":"Crossref","is-referenced-by-count":17,"title":["A novel way to investigate the effects of plasma exchange on antibiotic levels: use of microdialysis"],"prefix":"10.1016","volume":"31","author":[{"given":"Jason A.","family":"Roberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheree E.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lipman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2007.09.013_bib1","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2007.09.013_bib2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1046\/j.1537-2995.2003.00397.x","article-title":"Therapeutic apheresis: a summary of current indication categories endorsed by the AABB and the American Society for Apheresis","volume":"43","author":"Smith","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.ijantimicag.2007.09.013_bib3","first-page":"269","article-title":"Clinical pharmacokinetics during plasma exchange","volume":"55","author":"Fauvelle","year":"2000","journal-title":"Therapie"},{"key":"10.1016\/j.ijantimicag.2007.09.013_bib4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/jca.10074","article-title":"Extracorporeal removal of antimicrobials during plasmapheresis","volume":"18","author":"Kintzel","year":"2003","journal-title":"J Clin Apher"},{"key":"10.1016\/j.ijantimicag.2007.09.013_bib5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2165\/00003088-200645080-00001","article-title":"Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis","volume":"45","author":"Roberts","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2007.09.013_bib6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0025-7125(16)30056-6","article-title":"Antibiotic treatment of sepsis","volume":"79","author":"Cunha","year":"1995","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.ijantimicag.2007.09.013_bib7","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1097\/01.CCM.0000098031.24329.10","article-title":"Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis","volume":"31","author":"Garnacho-Montero","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2007.09.013_bib8","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/cc4995","article-title":"Timing of adequate antibiotic therapy is more determinant of outcome than TNF and IL-10 polymorphisms in septic patients","volume":"10","author":"Garnacho-Montero","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2007.09.013_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.amjmed.2003.07.005","article-title":"Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis","volume":"115","author":"Harbarth","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2007.09.013_bib10","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1378\/chest.115.2.462","article-title":"Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients","volume":"115","author":"Kollef","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2007.09.013_bib11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1086\/379825","article-title":"Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial","volume":"38","author":"MacArthur","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.09.013_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00003246-200102000-00030","article-title":"Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock","volume":"29","author":"Joukhadar","year":"2001","journal-title":"Crit Care Med"},{"issue":"Suppl. D","key":"10.1016\/j.ijantimicag.2007.09.013_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/31.suppl_D.1","article-title":"Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans","volume":"31","author":"Ryan","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2007.09.013_bib14","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2007.09.013_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0169-409X(00)00106-X","article-title":"Microdialysis in peripheral tissues","volume":"45","author":"de la Pena","year":"2000","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ijantimicag.2007.09.013_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0169-409X(00)00107-1","article-title":"Methodological issues for microdialysis sampling for pharmacokinetic studies","volume":"45","author":"de Lange","year":"2000","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ijantimicag.2007.09.013_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.ijantimicag.2007.09.013_bib18","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1177\/106002809703101003","article-title":"Removal of vancomycin during plasmapheresis","volume":"31","author":"McClellan","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijantimicag.2007.09.013_bib19","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1128\/AAC.37.5.1171","article-title":"Influence of therapeutic plasmapheresis on elimination of ceftriaxone","volume":"37","author":"Bakken","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2007.09.013_bib20","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/AAC.38.7.1519","article-title":"Pharmacokinetics of ceftriaxone during plasma exchange in polyarteritis nodosa patients","volume":"38","author":"Fauvelle","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2007.09.013_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00544567","article-title":"Kinetics of ceftazidime during plasmapheresis","volume":"33","author":"Bozkurt","year":"1987","journal-title":"Eur J Clin Pharmacol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907004876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907004876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T17:05:21Z","timestamp":1557075921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857907004876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0924857907004876"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.09.013","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}